UNSPSC 51342502: Alovudine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51342502

Definition

This classification denotes a reverse transcriptase inhibitor with the molecular formula C10H13FN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PG53R0DWDQ, chemically known as thymidine, 3-deoxy-3-fluoro- but generally known as alovudine, which bears US NIH Compound Identifier 33039. European Medicines Agency schedules Alovudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05359MIG.

Read the full definition

The term ALOVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ALOVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alovudine under HS 29349990 and SITC 51579. As of Q4 2014, ALOVUDINE remains the US FDA Preferred Term for this commodity. Alovudine bears US NLM identifiers UMLS ID C0206795 and NCI Concept Code C65226. SMILES: CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F.

About UNSPSC 51342502

UNSPSC 51342502 Alovudine, a Commodity code, covers pharmaceutical products procured by state and local health departments and county public health agencies for emergency preparedness, disease control, and community health initiatives. The recent solicitations tagged to this code show state and local governments buying antiviral and emergency response medications through competitive bidding and piggyback cooperative purchasing vehicles, though the opportunities posted under the code name do not consistently feature alovudine itself — instead, Illinois Department of Public Health and Seminole County, Florida have solicited related pharmaceutical products including antibiotic tablets, naloxone, and drug deactivation systems. Issuing bodies include state health departments and county health authorities, with purchases structured as fixed-fee contracts with multi-year terms and renewal options to support ongoing public health operations.

Recent activity appears concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with a 12-month initial term and two renewal options. Seminole County, Florida released an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, requiring all shipping and delivery costs included in vendor bids and compliance with E-Verify and drug-free workplace certification. Both contracts include standard insurance and compliance requirements; the Seminole County procurement notes potential FEMA funding with associated federal regulatory compliance obligations.

Quick answers

What is UNSPSC 51342502?

UNSPSC 51342502 is Alovudine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51342502?

UNSPSC 51342502 maps to 1 NIGP code, 26908 Anti-Infective Agents.

On GovTribe

See everything under UNSPSC 51342502

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code